QA: Citius Pharmaceuticals Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001506251_2025_Citius_Pharmaceuticals_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001506251, Citius Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 14,220,646
1 IntangibleAssetsNetIncludingGoodwill 9,346,796
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 93,084,309
4 LiabilitiesCurrent 35,814,803
5 LiabilitiesNoncurrent 21,318
6 remainder_Liabilities 6,713,800
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,662,829
9 ResearchAndDevelopmentExpense 12,513,139
10 remainder_Expenses 27,036,586
11 remainder_Revenues 0
12 remainder_NetIncome 3,505,293
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 116,651,751
1 Liabilities 42,549,921
2 Expenses 60,212,554
3 Revenues 0
4 StockholdersEquity 74,101,830
5 NetIncome -56,707,261
6 ComprehensiveNetIncome -56,707,261
7 BaseVar 111,459,760
8 EconomicCapitalRatiobeforeLimitedLiability 1.32
9 EconomicCapitalRatio 2.54

Edgar->Model Mapping

Feature Distribution

Change over Time